Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly. For true longs, getting to the $50 range might get you back to break even and many years of lost investment time.
They have their work cut out even staying in the $1 range for NASDAQ.
If MDT figures positively in any news they release, that will help.
Otherwise, their wad is already shot on yesterday's lifeline.
Sorry to be cynical but Titan has never failed to disappoint.
For MDT this may just be a cheaper and safer option than the expense and risk of fighting some fundamental patent issue with Titan.
If Medtronic is committed to the Hugo platform then they are just paying off Titan now in increments until Titan disappears or maybe McNally eventually decides to let a buyout proceed.
If Medtronic is committed to Hugo(and continually developing) Hugo, what is the point of interacting with Titan and its COMPLETELY DIFFERENT hardware and software?
As late as Feb 2020:
Medtronic buys British surgical AI company, adding to Hugo robot effort.
So what is the point of Medtronic expending any capital or energy on the Titan platform? We all acknowledge Medtronic is literally keeping us alive with this deal. I'll take anything I can get at this point personally: don't think I'm knocking the good news.
But do they just want some specific IP from Titan?
If Titan could even possibly succeed with Sport independently it would be a competitor to Hugo. Why would Medtronic allow that to happen? This half-committment deal is very strange.
I think Medtronic is simply going to bleed Titan for IP, while smiling nicely. McNally has no options but to take the knife.
I only need $48/share to break even.
Titan still is a turd in my book.
Haven't visited for a while since I basically have forgotten Titan as an investment. Haven't sold because miracles can happen; barely worth the effort to sell anyway.
SPORT is a technologically good, maybe even great, design, with no end of potential for continued improvement as a platform. It should be an alternative platform with DaVinci. Hell, it is basically ready to put in use now, except for the destructive time and cost of regulatory approval.
What didn't materialize was a market for it. Most surgeons are training as they always have and content with the state of their art and any niche technology aids. I know many good surgeons who couldn't care less about SPORT. If any of the big player medical companies thought they could really push SPORT to premier platform status under their name they would have bought it up long ago. Management would have accepted a high-enough price if offered.
Despite all the rosy projections, there has just never been a market. DaVinci was a fortuitous aberration, just like Apple was in personal computing technology. Forty years later, Apple is still Apple, nobody else quite like them or in their "space", even if they are finally loosing their steam which was Steve Jobs.
My prediction: there will be no next DaVinci, just multiple niche players for surgical specialties. For at least 10 years. Then they will coalesce under some international information standard, like the Verb concept. By that time, SPORT technology will have been superseded. The patent holders may make some money in the short term.
Management's mistake has always been to try and go it alone.
I don't fault myself for investing in Titan. Lots of reasons to think it was a good idea. Kudos though, to those who read the market disinterest clearly (and let's admit it has been staring us in the face for the last 6-7? years), and managed their exit to avoid the worst losses.
Give it up.
If there is a god maybe a miracle will happen.
I'm happy to report that even my wife understands the risk I took on a lifetime chance to make significant gains, and the loss I incurred when it did not happen.
I check this site maybe once a month. This shitshow is the classic example of getting in way, way, way, way, way, way too early for such a difficult piece of technology in the FDA sector. Think of it: we were pumping in significant family monies when this was just a pipe-dream cutting chicken in a bottle with an old clown and his daughter at the helm. Seems laughable now. The SPORT technology is even dated now.
If you survive the coming Covid-19 disaster (world-wide depression, let alone a 1/20 chance of dying), consider yourself blessed.
I wouldn't put a morning dump, let alone a penny, in this POS.
Probably 30 separate stock purchases over the years, and not a cent of gain, ever. It defies belief.
Best to all.
That has ALWAYS been the question. I believed it was, and even if not perfect there was plenty of market space where it would be useful, and could sell. The greatest question, which we all know, is why TMDI was never able to drum up an offer to partner with someone with big pockets. The simple answer has always been that without approval/very near approval, no one could touch it at any price McNally would be willing to sell it. I'd love to know what companies must have given at least cursory consideration to offering to buy them out.
I find it really hard to believe that with all the forward progress of the last 2? years, this was all a bunch of crap so that McNally could just collect his paycheck.
I'm resigned to considering my long investment a total loss, at this point. They could fold overnight. A firesale would still be a total loss as far as I can see.
The only thing McNally can say of note is we are for sale, we have a big pockets partner, or we are ready to submit for CE/FDA. Nothing else will raise the price even 20 cents. To double stock price from here is a pipe dream until we are in the approval pipeline.
Hell, many longs need a 30x gain just to break even.
Titan has already established Cashectomy from its longs.
As a member of a PREMIER hospital medical devices committee, I can ASSURE you that the decision to purchase (and commit) to a system like SPORT is an EASY 1-2 YEARS from the time some surgeon COMES TO THE CONCLUSION that this is the future for their practice and serves the needs of the institution. That is, after slow acceptance, publications, conference presentations, etc..
Therefore, we are talking (in the best possible timeframe with all things going Titan's way):
2020 for the early sales +2 build up of early user base+ 2 years for major institutions to move into SPORT use.
Looking forward to 2024 (I'll be 66 years old) to hopefully start to see some investment return.
Given that I invested heavily 6+ years ago (when the price/return was very optimistic with a mock-up and a chicken meat demo), I could probably done much better in a long term CD (10 years), without risk. Risk which I must still endure for many more years.
LONGS ARE SCREWED. Sorry, but that is the reality of Titan.
LONGS ARE SCREWED. It hurts.
If you want to throw more money on the roulette wheel, or can afford to, by all means ago ahead.
LONGS ARE SCREWED. I won't make this mistake again. OTC, non-US start-up, hayseed for a CEO, bozo for a CFO, and an empty office as an address.
LONGS ARE SCREWED.
A_F*in_MEN!!
Exactly.
If I had myself down to a breakeven of $5, I'd have a hell of a lot more money tied up to lose.
And not one iota more confidence that I'll ever get to $5, given the history of this company.
Dilution kills; it's a one way steet if pps never rises to offset. That's what happens when healthy positive speculation is in play.
HC, I agree we REALLY are at a crossroads. Nothing in the foreseeable future to spark interest in the stock. Lack of interest has been proven now for 5+ years. I can't explain it because from a product development viewpoint and market-potential viewpoint it makes NO G-D- SENSE.
I truly believe the only thing that can kick some life into this investor's nightmare manure pile is talk of selling out completely, or literally submitting for regulatory approval. No new board member, new patent, new CEO, new video, new investor's conference, new stapling tool, new supplier, new blurb in a trade journal, etc., etc.. will move this POS beyond a dribble of a few cents up.
Dilution caused by piddling raises is like taking poison every day; it's a slow death. Ever increasing estimates of finalizing costs don't help either.
I really though getting on NASDAQ as TMDI was going to make a difference, with exposure at the very least.
Unfortunately, this is still a crappy penny stock being run out of an empty cheap office in Toronto.
Not averaging down over the last few years would have thrown good money after bad, in retrospect; I'm glad I resisted the temptation.
Only need $56/sh to break even, LOL.
McNally better do something real fast. I'll settle for shares in a real company.
NOTHING HAS EVER "BROUGHT THE PRICE UP"!!!
NO MATTER HOW GOOD THIS DEVICE LOOKS, STILL NO ONE IS INTERESTED.
ONLY ONE THING WILL PUT US ON THE MAP: REGULATORY APPROVAL.
More like negotiating a sale.
It never "bounces back with a fury". Are you nuts?
Investors want to know SPORT IS GOING TO THE FDA!!!!!!!!!!!!!!!
That's when they will do a little research and roll their F'ing dice. All this PR shit is (obviously by now) NOT GOING TO CUT IT!!
No one frickin' cares.
The moment Titan finally says design and development are frozen and we are in regulatory submission (US or Europe), then we go up. Then we are known as the next legimate contender in this sector.
One Titan-only review in any of the legitimate investment publications will also help. Not some medical industry rag sheet, or investor conference.
This BS PR of patents, board members, obscure surgical trials, training program development, etc., is all good, but 5+ years of that stuff hasn't done SH*T to raise organic interest.
I expect we will be sold off to someone that can actually finish the job, for pennies.
This stock should be selling itself, at this advanced stage in SPORT development.
Amazingly, in contrast to so many other startups, Titan has actually developed a real, market worthy technology, functionally prototyped, and supported by patents and professional testing. It has been a long road for both the visionaries and the investors.
But it was mismanaged early on by people with know-how inappropriate to the task (Fowler, Reiza, Hargrove, Randall, and others).
Yet here we are; if we were in the hands of a large medical tech company for the past two years or so, we would already be in FDA testing and reaping the share price benefits of becoming the first competitor to ISRG.
My guess at this point is that McNally will be forced to sell the entire package to someone (for a firesale price)just so the "principals" can walk off with their profit. There it will either fizzle out (ie. bogged down with lawsuits from Columbia, MicroLine, Ximedica, shareholders,or actually become a dominant product).
My holdings aren't worth enough to bother selling. Might as well wait for a miracle.
These M-Fuckers need an article in WSJ. Until then, no matter WHAT THE TECHNOLOGY LOOKS LIKE, we are 3 years out from seeing even $15.
This POS is cursed. They can take their PR and shows and shove them. They need to get themselves mentioned as the next big thing, in some legitimate venue. But they won't; McNally wants to keep open the option to bail.
Try to reference one PR that did more to raise the price, for 2 days, over 10%.
Six years (and counting) in Hell.
Waiting for $50 and I'll have only lost 6 years and loose change.
TMDI is cursed!
NO organic interest! Why!!????
I'll break even on this POS at $56/sh. Minus 6+
years lost, of course.
May take a while to get there, LOL.
Thanks for the explanation, Mustang.
SPORT appears to be a functional platform, right now.
Does it really need a MINIMUM of $50 million more to take it to the FDA??? Really??? That's $2 million a month if this stretches out 24 more months.
$50 million should be able to buy A LOT of coding and some engineering tweaks and testing to bring this thing to the FDA's doorstep.
I can't believe these numbers for additional cash needed.
I think McNally is padding this out way too much.
In retrospect, for the last 5+ years I have been in this stock, there is only ONE COMMON DENOMINATOR I can see as the common thread responsible for the performance of this POS investment. And that factors in delays, false timelines, crappy management, over-exuberant expectations, economic downturns and upturns, hires and fires, etc....
It is the crappy exchange it is on.
I don't care what a R/S does to price in the short term. Titan needs exposure to real capital on a market where people will be exposed to the serious abilities of SPORT to be the next widely adopted surgical platform.
We can not afford to waste any more time.
Even MacNally knows the money won't come in under these conditions. Christ, we we're a couple $$/share when there was Nothing, nothing compared to where the machine is now.
McNally is going to kill this thing unless he cuts the never-ending time and cash line and starts trying to get this pig into the approval process.
What would be huuugggeee would be to a release info on submission to FDA. What the hell do board members have to do with anything? We've been through a few; McNally makes the decisions; we always need more money and time. There are some technologies that failed BECAUSE they took too far long to develop, and begin establishing real-world presence that THEN takes them to the next level.
Impossible to believe that much more money and time is required.
Given what we see...
Let's partner and get this thing on the road. jeezz...
Yea, thinning out for me because I've spent wayyyyy too much time with this POS.
I need $1.87/share to "break even" after 5 years wasted investment time and money I could have enjoyed doing something with. Not even worth recouping the pittance it is worth now.
I look at the price every week or two. Board messages are not worth reading. Same stuff over and over and over. No amount of good news moves this turd. Never made a purchase of it that went black, even for a day.
Diluted to death; 18 cents a share for the next great robotics platform.
When it's in the hands of the FDA, I'll care again.
I read every message daily on this board for years. Can't waste my time anymore. All the money I'm willing to risk is in, and I'm deeply in the red.
At one time I cared about the technology, science, and engineering of SPORT, snooped around for clues and connections. Now, all that matters is that it makes it to market and sells.
Still believe that it will "succeed", at least enough to make it into the black in the next 2-5 years. It will never have anywhere near ISRG's success for investors.
So what I do now is pull up the board, glance at the last 3-4 messages. Unless something screams "NEWS!!!", I click the last one.
A quick glance at price (red or green) and volume, and that's it for ihub TITXF for the day.
Makes my life a lot easier.
Great find, but was it intended for public dissemination?
Needed one of those for the past 4 years.
Potential new robotic system enters into the mix:
http://www.massdevice.com/riverfield-surgical-robot-laboratory-raises-10m-challenge-intuitive-surgical-japan/
Nice idea!
It is likely that some members on the SAB really never had anything practical to do. I'd love to know otherwise, but that is frequently the case in academically affiliated institutions.
Maybe they were paid a stipend, made a once a year meeting, put it on their CVs; who knows? Let's ask Raymond Reiza or Reiza Rayman, whatever? We don't even know what he did, for years.
Todd Pope says to temper the enthusiasm for Senhance:
https://www.medtechy.com/the-ticker/articles/2017/whats-next-for-transenterix-after-senhances-fda-approval
Interesting read. I think he is laying the groundwork for imminent disappointment for Senhance sales.
News needs to be continuous now McNally; keep the momentum.
I'm in at $1.87 starting with buys 4-5 years ago, and frankly I thought this thing was being driven off the cliff by JH, RR, Fowler and crew. I didn't sell at huge loss because I could afford not to and just roll the dice on the dregs remaining of my investment.
I have not had the stomach to average down.
That the two great pops in pps, yesterday's news about the surgeon investment, and McNally taking the helm tell me one thing:
There are huge amounts of people that believe SPORT is the real thing, but have (had) just lost or have no faith that Titan could make it. It also shows from the lukewarm or zero response at all the investment presentations. If you can't raise money from those its obvious you are considered a lost cause.
Yesterday's news was actual validation, better than FDA in a sense. Remember, even getting evaluated at Nicholson and the other two sites (would love to hear about those McNally!!) is a paid-for deal. Investors still didn't believe; those that even knew about Titan since we have been one of the most off-the-radar startups I have ever seen.
If this new action doesn't turn the Titan world around I don't know what will. Please McNally, keep the PR up. No more month(s) long radio silences, ever.
Not without continued news.
Agree, just trying to see things in proper scale.
I am happily surprised at the volume and rise today.
Can only hope there will be more private group buys based on the excitement generated.
These "surgeons" already made good money, and they know now that they are their own PR machine. That's a positive feedback loop that could take this fundraising quite far.
GREAT!!
2.9M CDN = 2.3 M USD
The PR was "over a dozen surgeons" and a few others.
Let's assume that's at least 20 people.
Average of $115,000 USD each.
Many on this board have put in more than that.